Blueprint Investment Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-4,847
| Closed | -$861K | – | 97 |
|
|
2024
Q4 | $861K | Sell |
4,847
-1,932
| -28% | -$343K | 0.14% | 83 |
|
|
2024
Q3 | $1.34M | Buy |
6,779
+2,001
| +42% | +$395K | 0.24% | 56 |
|
|
2024
Q2 | $820K | Sell |
4,778
-2,327
| -33% | -$399K | 0.18% | 60 |
|
|
2024
Q1 | $1.29M | Buy |
7,105
+2,868
| +68% | +$522K | 0.26% | 51 |
|
|
2023
Q4 | $657K | Buy |
4,237
+1,621
| +62% | +$251K | 0.18% | 60 |
|
|
2023
Q3 | $390K | Buy |
+2,616
| New | +$390K | 0.13% | 80 |
|
|
2023
Q2 | – | Sell |
-4,479
| Closed | -$714K | – | 144 |
|
|
2023
Q1 | $714K | Sell |
4,479
-6,611
| -60% | -$1.05M | 0.16% | 83 |
|
|
2022
Q4 | $1.79M | Buy |
11,090
+4,997
| +82% | +$808K | 0.38% | 60 |
|
|
2022
Q3 | $818K | Sell |
6,093
-2,166
| -26% | -$291K | 0.22% | 64 |
|
|
2022
Q2 | $1.27M | Buy |
8,259
+2,793
| +51% | +$428K | 0.34% | 51 |
|
|
2022
Q1 | $886K | Buy |
5,466
+691
| +14% | +$112K | 0.23% | 76 |
|
|
2021
Q4 | $647K | Buy |
4,775
+1,565
| +49% | +$212K | 0.16% | 101 |
|
|
2021
Q3 | $346K | Buy |
+3,210
| New | +$346K | 0.17% | 87 |
|
|
2021
Q2 | – | Sell |
-1,944
| Closed | -$210K | – | 76 |
|
|
2021
Q1 | $210K | Buy |
+1,944
| New | +$210K | 0.16% | 64 |
|